Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.

Autor: Peters NA; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Constantinides A; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Ubink I; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., van Kuik J; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Bloemendal HJ; Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands.; Department of Internal Medicine/Oncology, Radboud University Medical Center Nijmegen, Nijmegen, Netherlands., van Dodewaard JM; Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands., Brink MA; Department of Gastroenterology, Meander Medical Center, Amersfoort, Netherlands., Schwartz TP; Department of Gastroenterology, Meander Medical Center, Amersfoort, Netherlands., Lolkema MPJK; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, Netherlands., Lacle MM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Moons LM; Department of Gastroenterology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Geesing J; Department of Gastroenterology, Diakonessenhuis, Utrecht, Netherlands., van Grevenstein WMU; Department of Surgical Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Roodhart JML; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Elias SG; Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Borel Rinkes IHM; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.; Department of Surgical Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Kranenburg O; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

Publikováno v: Frontiers in oncology [Front Oncol] 2022 Sep 06; Vol. 12, pp. 969855. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022).

Tumour-stroma ratio has poor prognostic value in non-pedunculated T1 colorectal cancer: A multi-centre case-cohort study.

Autor: Dang H; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands., van Pelt GW; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands., Haasnoot KJ; Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Backes Y; Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Elias SG; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Seerden TC; Department of Gastroenterology and Hepatology, Amphia Hospital, Breda, The Netherlands., Schwartz MP; Department of Gastroenterology and Hepatology, Meander Medical Centre, Amersfoort, The Netherlands., Spanier BW; Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, The Netherlands., de Vos Tot Nederveen Cappel WH; Department of Gastroenterology and Hepatology, Isala Clinics, Zwolle, The Netherlands., van Bergeijk JD; Department of Gastroenterology and Hepatology, Gelderse Vallei, Ede, The Netherlands., Kessels K; Department of Gastroenterology and Hepatology, Sint Antonius Hospital, Nieuwegein, The Netherlands., Geesing JM; Department of Gastroenterology and Hepatology, Diakonessenhuis, Utrecht, The Netherlands., Groen JN; Department of Gastroenterology and Hepatology, Sint Jansdal, Harderwijk, The Netherlands., Ter Borg F; Department of Gastroenterology and Hepatology, Deventer Hospital, Deventer, The Netherlands., Wolfhagen FH; Department of Gastroenterology and Hepatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Seldenrijk CA; Pathology DNA, Sint Antonius Hospital, Nieuwegein, The Netherlands., Raicu MG; Pathology DNA, Sint Antonius Hospital, Nieuwegein, The Netherlands., Milne AN; Pathology DNA, Sint Antonius Hospital, Nieuwegein, The Netherlands., van Lent AU; Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., Brosens LA; Department of Pathology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Offerhaus GJA; Department of Pathology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Siersema PD; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands., Tollenaar RA; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands., Hardwick JC; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands., Hawinkels LJ; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands., Moons LM; Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Lacle MM; Department of Pathology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Mesker WE; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands., Boonstra JJ; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.

Publikováno v: United European gastroenterology journal [United European Gastroenterol J] 2020 Nov 19, pp. 2050640620975324. Date of Electronic Publication: 2020 Nov 19.

Macrophages induce "budding" in aggressive human colon cancer subtypes by protease-mediated disruption of tight junctions.

Autor: Trumpi K; UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Frenkel N; UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Peters T; UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Korthagen NM; Orthopedics, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands., Jongen JMJ; UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Raats D; UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., van Grevenstein H; UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Backes Y; Gastroenterology & Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands., Moons LM; Gastroenterology & Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands., Lacle MM; Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Koster J; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Zwijnenburg D; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Borel Rinkes IHM; UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Kranenburg O; UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.

Publikováno v: Oncotarget [Oncotarget] 2018 Apr 13; Vol. 9 (28), pp. 19490-19507. Date of Electronic Publication: 2018 Apr 13 (Print Publication: 2018).

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.

Autor: Rigter LS; Department of Gastroenterology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Spaander MC; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Moons LM; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands., Bisseling TM; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands., Aleman BM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Boer JP; Department of Hematology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Janus CP; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Petersen EJ; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Roesink JM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Raemaekers JM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Maazen RW; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Cats A; Department of Gastroenterology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Bleiker EM; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Snaebjornsson P; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Carvalho B; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Lansdorp-Vogelaar I; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Jóźwiak K; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Te Riele H; Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands., Meijer GA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Leerdam ME; Department of Gastroenterology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. m.v.leerdam@nki.nl.

Publikováno v: BMC cancer [BMC Cancer] 2017 Feb 07; Vol. 17 (1), pp. 112. Date of Electronic Publication: 2017 Feb 07.

Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study.

Autor: Kappelle WF; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands., Valk GD; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Leenders M; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands., Moons LM; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands., Bogte A; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands., Siersema PD; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands., Vleggaar FP; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.

Publikováno v: Endoscopy [Endoscopy] 2017 Jan; Vol. 49 (1), pp. 27-34. Date of Electronic Publication: 2016 Dec 14.